Published within
|«
«
|
...
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
...
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Report
|
Analysis of current treatment dynamics of prostate cancer. The report assesses uptake rates and order or treatment types across the seven major markets using Datamonitor’s primary physician research of 124 medical oncologists and urologists.
Published By Datamonitor
|
21 Dec 2011 |
$4800
|
Report
|
Overview of migraine, disorder definition, and a review of epidemiology literature. This report provides in-depth analysis of patient populations, a 10-year prevalent case forecast, and key patient segments across the seven major markets.
Published By Datamonitor
|
21 Dec 2011 |
$2800
|
Report
|
An overview of partnering trends in developed and emerging pharmaceutical markets in the Asia Pacific region from Q3 2010 to Q2 2011, with discussion of the drivers of recent deals and analysis of key deals and agreements in individual countries.
Published By Datamonitor
|
21 Dec 2011 |
$4800
|
Exclusive online offer: order this report by November 9th and save 20%
To take advantage of this offer enter Promo Code BIO2012 when prompted in the checkout
More information
|
Report
|
This report provides an analysis of strategies employed by the top 50 pharma companies that are active or plan to enter the biosimilars sector in the future, together with an analysis of biosimilar deal trends among the top 50 pharma companies.
Published By Datamonitor
|
20 Dec 2011 |
$2800
|
Report
|
In-depth analysis of key brands and pipeline agents indicated for the treatment of epilepsy. Provides a comparative evaluation of clinical and commercial drug attributes to determine competitiveness in the marketplace.
Published By Datamonitor
|
20 Dec 2011 |
$6400
|
Report
|
In-depth analysis of key prescription brands and pipeline agents for the treatment of insomnia. Provides a comparative evaluation of clinical and commercial drug attributes to determine competitiveness in the marketplace.
Published By Datamonitor
|
19 Dec 2011 |
$6400
|
Report
|
With a recent boost in sales, Spiriva leads the Chinese COPD market. A number of once-daily monotherapy and combination bronchodilators threaten its dominance in the next 10 years, but the brand’s wide patient potential will insulate its position.
Published By Datamonitor
|
14 Dec 2011 |
$6400
|
Report
|
In depth analysis of key brands and pipeline agents indicated for the treatment of osteoporosis. Provides a comparative evaluation of clinical and commercial drug attributes to determine competitiveness in the marketplace.
Published By Datamonitor
|
14 Dec 2011 |
$6400
|
Report
|
In depth analysis of key brands and pipeline agents indicated for the treatment of multiple sclerosis. Provides a comparative evaluation of clinical and commercial drug attributes to determine competitiveness in the marketplace.
Published By Datamonitor
|
12 Dec 2011 |
$6400
|
Report
|
The large number of Chinese CV & metabolic diseases patients brings significant commercial opportunities for Pharma. Plans to expand insurance coverage and improve healthcare infrastructure will enhance therapy access, boosting the market potential.
Published By Datamonitor
|
09 Dec 2011 |
$2800
|
|«
«
|
...
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
...
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.